Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mullarkey

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Genetics|January 1, 1997
Chromosome deletion 17p11.2 (Smith-Magenis syndrome) in seven new patients, four of whom had been referred for fragile-X investigationF Behjati, M Mullarkey, A Bergbaum, et al.
Cancer Genetics and Cytogenetics|July 29, 2000
Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridizationC J Breen, A O'Meara, M McDermott, et al.
Cytogenetics and Cell Genetics|April 30, 2002
Genetic abnormalities in a pre and post-chemotherapy hepatoblastomaM Mullarkey, C J Breen, M McDermott, et al.
Lancet (London, England)|October 16, 1971
Effect of diagnostic ultrasound on maternal and fetal chromosomesU Abdulla, C J Dewhurst, S Campbell, et al.
Cancer Genetics and Cytogenetics|September 24, 2004
Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastomaR L Stallings, P Carty, L McArdle, et al.
Cancer Genetics and Cytogenetics|March 21, 2003
Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?R L Stallings, J Howard, A Dunlop, et al.
Lancet (London, England)|October 23, 1993
Cytogenetic versus DNA diagnosis in routine referrals for fragile X syndromeQ Wang, E Green, A Barnicoat, et al.
Cytogenetic and Genome Research|June 26, 2004
Evolution of unbalanced gain of distal chromosome 2p in neuroblastomaR L Stallings, P Carty, L McArdle, et al.
American Journal of Medical Genetics|June 15, 1993
Complete and partial XY sex reversal associated with terminal deletion of 10q: report of 2 cases and literature reviewA O Wilkie, F M Campbell, P Daubeney, et al.
Chest|April 1, 1996
A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment?H J Schwartz, M Blumenthal, R Brady, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Genetics|January 1, 1997
Chromosome deletion 17p11.2 (Smith-Magenis syndrome) in seven new patients, four of whom had been referred for fragile-X investigationF Behjati, M Mullarkey, A Bergbaum, et al.
Cancer Genetics and Cytogenetics|July 29, 2000
Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridizationC J Breen, A O'Meara, M McDermott, et al.
Cytogenetics and Cell Genetics|April 30, 2002
Genetic abnormalities in a pre and post-chemotherapy hepatoblastomaM Mullarkey, C J Breen, M McDermott, et al.
Lancet (London, England)|October 16, 1971
Effect of diagnostic ultrasound on maternal and fetal chromosomesU Abdulla, C J Dewhurst, S Campbell, et al.
Cancer Genetics and Cytogenetics|September 24, 2004
Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastomaR L Stallings, P Carty, L McArdle, et al.
Cancer Genetics and Cytogenetics|March 21, 2003
Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?R L Stallings, J Howard, A Dunlop, et al.
Lancet (London, England)|October 23, 1993
Cytogenetic versus DNA diagnosis in routine referrals for fragile X syndromeQ Wang, E Green, A Barnicoat, et al.
Cytogenetic and Genome Research|June 26, 2004
Evolution of unbalanced gain of distal chromosome 2p in neuroblastomaR L Stallings, P Carty, L McArdle, et al.
American Journal of Medical Genetics|June 15, 1993
Complete and partial XY sex reversal associated with terminal deletion of 10q: report of 2 cases and literature reviewA O Wilkie, F M Campbell, P Daubeney, et al.
Chest|April 1, 1996
A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment?H J Schwartz, M Blumenthal, R Brady, et al.
Pageof 2